InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,503.38
(
0.30%
)
US TECH 100
19,439.60
(
0.16%
)
Dow Jones
38,943.72
(
0.28%
)
Brent Oil
85.21
(
0.60%
)
Bitcoin
65,207.49
(
0.37%
)
Post# of 10489
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

MDMSCF

Send PM Follow Ignore
Followers 0
Posts 37
Boards Moderated 0
Alias Born 10/16/2013

MDMSCF

Re: None

Wednesday, 11/12/2014 7:46:27 AM

Wednesday, November 12, 2014 7:46:27 AM

Post# of 10489
NeuVax Phase 3 trial entering key moments. If interim results are reported (70 events) in Nov. - Dec. NeuVax < 20% reduction in DFS, after March NeuVax > 30% reduction in DFS.
Bashers don't have much longer to bash!
I expect a run-up will start in Jan. or Feb. if interim data has not been announced by then.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up